financetom
Business
financetom
/
Business
/
GSK seeks FDA nod for expanded use of RSV vaccine in adults
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GSK seeks FDA nod for expanded use of RSV vaccine in adults
Jul 13, 2025 11:33 PM

July 14 (Reuters) - British drugmaker GSK said

on Monday it had submitted an application to the U.S. Food and

Drug Administration to extend the use of its respiratory

syncytial virus (RSV) vaccine, Arexvy, to adults under the age

of 50 at a higher risk of the disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved